Sbir topic 355: a 3D perfusable platform for HTS across diverse racial/ethnic cancer specimens to generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer cultures in…
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700015C
- Awardee
-
Mimetas US Inc. UEI QGP7JLTGMAK9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $297,962
Award facts
- Opportunity
-
- PHS20171OMIBUS Solicitation number
- Contract value 100% obligated
- $297,962.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) contract to Mimetas US, Inc., a small disadvantaged business, in the amount of $297,962.00. The contract is for the development of a 3D perfusable platform for high-throughput screening (HTS) across diverse racial/ethnic cancer specimens to generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer cultures in the Mimetas 3D OncoPlate high-throughput platform. This contract was set aside for total small business participation.
Description
Sbir topic 355: a 3D perfusable platform for HTS across diverse racial/ethnic cancer specimens to generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer cultures in mimetas 3D oncoplate high-throughput platform containing 96 EX vivo micro tumors.
Quick answers
Who was awarded contract HHSN261201700015C?
HHSN261201700015C was awarded to Mimetas US Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2017.
How much is contract HHSN261201700015C worth?
The government has obligated $297,962 on HHSN261201700015C.
Was contract HHSN261201700015C competed?
The extent of competition for HHSN261201700015C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award